Short Interest in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) Declines By 60.3%

M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) saw a large decrease in short interest during the month of January. As of January 15th, there was short interest totaling 60,397 shares, a decrease of 60.3% from the December 31st total of 152,225 shares. Based on an average daily volume of 381,391 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.2% of the company’s stock are sold short. Approximately 0.2% of the company’s stock are sold short. Based on an average daily volume of 381,391 shares, the days-to-cover ratio is currently 0.2 days.

Insider Buying and Selling

In related news, major shareholder Fitzgerald & Co. Cantor purchased 3,529,081 shares of the stock in a transaction on Wednesday, December 17th. The shares were bought at an average price of $10.80 per share, for a total transaction of $38,114,074.80. Following the completion of the acquisition, the insider directly owned 7,779,865 shares in the company, valued at approximately $84,022,542. This trade represents a 83.02% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Hedge Funds Weigh In On M3-Brigade Acquisition V

Hedge funds and other institutional investors have recently made changes to their positions in the company. Tuttle Capital Management LLC bought a new position in M3-Brigade Acquisition V during the second quarter worth about $437,000. Levin Capital Strategies L.P. bought a new position in M3-Brigade Acquisition V in the 2nd quarter valued at approximately $538,000. Wealthspring Capital LLC bought a new position in shares of M3-Brigade Acquisition V in the 2nd quarter valued at $2,715,000. MMCAP International Inc. SPC acquired a new stake in shares of M3-Brigade Acquisition V during the second quarter valued at about $16,935,000. Finally, Geode Capital Management LLC bought a new stake in M3-Brigade Acquisition V during the 2nd quarter worth approximately $1,978,000.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research report on Monday, December 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

M3-Brigade Acquisition V Stock Down 0.7%

Shares of M3-Brigade Acquisition V stock traded down $0.07 during trading hours on Friday, hitting $10.65. The company’s stock had a trading volume of 11,124 shares, compared to its average volume of 227,342. The stock has a 50 day moving average of $10.67 and a 200 day moving average of $10.61. M3-Brigade Acquisition V has a 12 month low of $10.10 and a 12 month high of $13.73.

M3-Brigade Acquisition V Company Profile

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.